Stability improvement of a liquid enzyme product.

AAPS PharmSciTech

Department of Pharmaceutical Development, Alcon R&D Laboratories, Camil Fabra 58, 08320, El Masnou, Spain.

Published: February 2010

The shelf-life of a previously developed two-part liquid-liquid enzyme ceruminolytic product was improved maintaining the same final reconstituted composition and re-formulating the liquid enzyme portion as a drug granulate by a double wet granulation process. The critical steps for the preparation of the granulate were studied (mixing/granulating times and drying) determining the proteolytic activity, the residual ethanol, and the moisture content of the granulates. The original liquid-liquid formulation had been proven effective as a ceruminolytic agent, but only had stability of greater than 75% enzyme activity for up to 18 months and up to 1 day at room temperature after combining the two parts. The resulting improved product was proven to be stable for up to 24 months at 30 degrees C, and up to 3 days at room temperature after combining the two parts. Therefore, maintaining the enzyme in a granulated form until reconstitution afforded an improvement in stability compared with the original two-part liquid-liquid formulation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799593PMC
http://dx.doi.org/10.1208/s12249-009-9327-xDOI Listing

Publication Analysis

Top Keywords

liquid enzyme
8
two-part liquid-liquid
8
liquid-liquid formulation
8
room temperature
8
temperature combining
8
combining parts
8
enzyme
5
stability improvement
4
improvement liquid
4
enzyme product
4

Similar Publications

Neonicotinoid insecticides have been widely applied in modern agriculture to improve crop productivity, but their residues have adverse impacts on the environment and human health. Hence, to address these issues, a portable self-powered/colorimetric dual-mode sensing platform was developed for the simple, rapid, precise, and sensitive on-site detection of acetamiprid (ATM) residues in vegetables. In this case, a multifunctional bioconjugate with specific recognition capability, excellent enzyme-like activity, and loading capacity is the key to the sensing design.

View Article and Find Full Text PDF

Gliomas are the most common brain tumor type in children and adolescents. To date, diagnosis and therapy monitoring for these tumors rely on magnetic resonance imaging (MRI) and histopathological as well as molecular analyses of tumor tissue. Recently, liquid biopsies (LB) have emerged as promising tool for diagnosis and longitudinal tumor assessment potentially allowing for a more precise therapeutic management.

View Article and Find Full Text PDF

Background: We aim to investigate efficacies of Ras homolog (Rho)-associated kinases (ROCK) inhibitors on Alzheimer's disease (AD) pathological proteins in human induced pluripotent stem cell (iPSC)-differentiated human neurons and the P301S tau transgenic mouse model (PS19).

Method: Quantitative liquid chromatography-mass spectrometry (LC-MS/MS) and targeted ELISA were implemented to investigate the effect of treatment with fasudil or its derivatives on the human neurons and brains from PS19 mice. We explored the efficacy of these ROCK inhibitors in reducing tau phosphorylation, and the brain proteomic profiles after their administration in mice.

View Article and Find Full Text PDF

Background: Synaptic loss predicts cognitive decline in Alzheimer's disease (AD). However, the critical disease modifying molecular mechanisms of synaptic failure remain elusive. Animal studies implicate the increased activation of cytosolic phospholipase (cPLA2) activation in synaptic loss and neuroinflammation.

View Article and Find Full Text PDF

Background: UFMylation is an understudied ubiquitin-like post-translational modification (PTM). Like ubiquitin, UFM1 is conjugated to substrates via a catalytic cascade involving a UFM1-specific E1 (UBA5), E2 (UFC1), and an E3 ligase complex (UFL1, DDRGK1 and CDK5RAP3). UFMylation is reversible, and this is mediated by UFSP2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!